about
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulationARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice.The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancersMNase titration reveals differences between nucleosome occupancy and chromatin accessibilityA molecular portrait of microsatellite instability across multiple cancersIntron retention is a widespread mechanism of tumor-suppressor inactivation.VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis.Prevalence and detection of low-allele-fraction variants in clinical cancer samples.Aging and neurodegeneration are associated with increased mutations in single human neurons.BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumorsGenomic footprints of activated telomere maintenance mechanisms in cancerPan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotranspositionComprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingAuthor Correction: BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumorsImmunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerMDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsAccurate detection of mosaic variants in sequencing data without matched controlsLinked-read analysis identifies mutations in single-cell DNA-sequencing dataAn enhanced genetic model of colorectal cancer progression historyIdentification of somatic mutations in single cell DNA-seq using a spatial model of allelic imbalanceDetecting the mutational signature of homologous recombination deficiency in clinical samplesMechanisms and therapeutic implications of hypermutation in gliomasPublisher Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingAuthor Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerParallel RNA and DNA analysis after deep sequencing (PRDD-seq) reveals cell type-specific lineage patterns in human brain
P50
Q30354457-E769CDC9-14F8-4CF8-8B0C-FADF07948040Q30354461-5BD2E065-F86D-4039-802F-3E93F27CF499Q30360829-76F46D66-CA5A-47A5-9781-2C5AC229F9E5Q34525346-60743F05-9B0D-4AD2-9FE5-9DF03EE928DCQ38741312-D2085B23-1D07-4353-A5D5-AFF2B218B0AAQ40466706-B40683FA-B069-4985-A597-1DF33F04E265Q41550097-8FD46152-74F2-4CB5-B0FB-5F64C7B888D3Q45370579-BC577CCF-3EEF-410B-B88B-F8E2917129D0Q47271432-D1A3514F-A041-4AE5-8A1B-19C91227E5C4Q64097493-6DFF32CC-70AF-4421-894A-16196D3AB4B2Q89555508-9911DFE4-E1AA-4569-9D7B-3276D60BE458Q89556828-946FD077-1886-472B-BF09-CFA5DB1F25C6Q89556873-9210476B-D2C2-4759-A3E4-60CE88917C51Q90317361-CDD0883B-1937-4FCE-9328-BEF26B3D8D97Q90470931-51C863F4-A79F-4848-BF0B-70CC7148059AQ91518584-06C14F66-5991-4E13-8610-1F5FA52310A8Q92453598-74C9B642-09E4-459B-B0B8-2756030C416FQ92461621-1B838666-28FE-4FD1-BF1C-FBFDF085F818Q92643926-B0432F0A-847A-462D-B9EB-6473CA766E32Q92994676-118FFD4D-03F0-4A1D-9FBF-44E35EAF9D72Q93112733-17F37503-B97D-49B3-9821-1BFC7DB11D41Q93164050-5863046D-EBB8-4D9E-A5AB-57E8BCEE6DE7Q94671674-DE2CCDD9-8389-4AD1-8444-323425FD44C7Q95324912-CA940EE6-8330-4FB6-8D50-3A287EA76207Q96302940-9C76F8B1-F234-4788-BD15-96A765ADF72A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Peter J Park
@en
Peter J Park
@nl
type
label
Peter J Park
@en
Peter J Park
@nl
prefLabel
Peter J Park
@en
Peter J Park
@nl
P31
P496
0000-0001-9378-960X